Fourteen‐and Ten‐Day Tegoprazan–Amoxicillin Dual Therapy vs. Bismuth Quadruple Therapy for Helicobacter pylori Eradication—A Noninferiority, Multicenter, Randomized Controlled Trial.

Saved in:
Bibliographic Details
Title: Fourteen‐and Ten‐Day Tegoprazan–Amoxicillin Dual Therapy vs. Bismuth Quadruple Therapy for Helicobacter pylori Eradication—A Noninferiority, Multicenter, Randomized Controlled Trial.
Authors: Fan, Yan1 (AUTHOR), Li, Chuanfei1 (AUTHOR), Zhang, Wenguang2 (AUTHOR), Shi, Jinlian3 (AUTHOR), Liang, Renzheng4 (AUTHOR), Deng, Meng5 (AUTHOR), Liao, Shengtao1 (AUTHOR), Xiao, Xiao6 (AUTHOR), Zhan, Ke7 (AUTHOR), Qiu, Liewang3 (AUTHOR) qiuliewang@cqmu.edu.cn, Mei, Zhechuan1 (AUTHOR) meizhechuan@cqmu.edu.cn, Lv, Lin1 (AUTHOR) 302207@hospital.cqmu.edu.cn
Source: Journal of Gastroenterology & Hepatology. Feb2026, Vol. 41 Issue 2, p657-666. 10p.
Database: Academic Search Ultimate
Description
ISSN:08159319
DOI:10.1111/jgh.70180